Newsroom

SAN FRANCISCO--(BUSINESS WIRE)--The honor places Innovaccer alongside past honorees like Microsoft, Meta, Chobani, Oracle, and Patagonia on the nation's most prestigious growth list....

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Buffer UCITS ETF - July 10.08.2026 FJUL.LN IE000YJBT6I5  100,002.00 USD   2,931,359.64   29.313  ...

BOLOGNA, Italy & MILAN, Italy--(BUSINESS WIRE)--Alfasigma S.p.A. (“Alfasigma”), a global pharmaceutical company, today announced that it has entered into a share purchase agreement with SEVER Life Sciences B.V. ("SEVER") for the sale of 100% of the shares of Nordic Group B.V. (“Nordic Pharma”) and its subsidiaries, a privately owned specialty pharmaceutical company with direct operations in Europe, Canada and Japan. The acquisition will add Nordic Pharma’s established rheumatoid arthritis busin...

BOSTON--(BUSINESS WIRE)--Carelon Research, a subsidiary of Elevance Health, and Manifold, an enterprise agent platform for life sciences, today announced a strategic partnership that gives life sciences researchers and data analysts secure, scalable access to high-quality, analysis-ready, real-world data in a protected environment, enabling faster, evidence-based decision-making. Through this collaboration, users can analyze Carelon Real World Data (RWD) alongside third-party datasets without m...

HENDERSON, Nev.--(BUSINESS WIRE)--Zura Bio Limited (Nasdaq: ZURA) (“Zura”), a clinical‑stage biotechnology company developing novel and differentiated medicines to meaningfully improve the lives of patients with serious and debilitating autoimmune and inflammatory diseases, today announced financial results for the second quarter ended June 30, 2026, and provided recent corporate updates. “The second quarter was marked by strong execution across our tibulizumab programs, with enrollment now com...

PALO ALTO, Calif.--(BUSINESS WIRE)--Pathway, an AI lab building a Post-Transformer architecture and models, today published benchmark results for BDH-CQ, a 150-million-parameter reasoning model. BDH-CQ scored 29.5% pass@2 on the public ARC-AGI-1 evaluation set at a computed inference cost of $0.0007 per task. Thanks to a new approach to reasoning, BDH-CQ runs approximately 11 times as cheaply per task as GPT 5.6 Luna (Low), even after accounting for OpenAI’s 80% price cut of 5.6 Luna on July 30...

TORONTO--(BUSINESS WIRE)--Legio Raises $5M Seed from Klass Capital to Modernize Campus Public Safety....

JERSEY CITY, N.J.--(BUSINESS WIRE)--HCPs, healthcare settings and pharmacies can begin REMS certification for Organon’s hormone-free copper IUD, MIUDELLA, ahead of upcoming launch....

DETROIT--(BUSINESS WIRE)--Together Women's Health (TWH) proudly announces its inclusion on the 2026 Inc. 5000 list for the fourth year in a row. This honor places Together Women's Health among the most dynamic businesses in America across all industries. Together Women's Health is a women's health-focused management service organization, committed to partnering with leading physicians to build a premier network of women's health services in the U.S. TWH's affiliate network consists of 27 practi...

NEW YORK--(BUSINESS WIRE)--Neurogene Inc. (Nasdaq: NGNE), a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced second quarter 2026 financial results and highlighted recent corporate updates. “The second quarter and recent months marked important progress across our NGN-401 program, highlighted by positive long-term Phase 1/2 data showing durable, multidomain developmental gains that have not be...